PharmX Technologies Reports Solid FY24 Growth

Corum Group Limited (AU:PHX) has released an update.

PharmX Technologies Ltd reported a strong financial performance for FY24, with a 9% revenue increase to $6.7 million, and underlying EBITDA up by 17%. The company successfully divested its legacy pharmacy software business, resolved a significant legal case, and demonstrated robust growth in its Gateway and Marketplace platforms. This positions PharmX well for future growth, underscored by strategic expansions and a solid cash reserve forecasted to exceed $4 million by year-end.

For further insights into AU:PHX stock, check out TipRanks’ Stock Analysis page.